These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27171010)

  • 1. Generation and Improvement of Effector Function of a Novel Broadly Reactive and Protective Monoclonal Antibody against Pneumococcal Surface Protein A of Streptococcus pneumoniae.
    Kristian SA; Ota T; Bubeck SS; Cho R; Groff BC; Kubota T; Destito G; Martin C; Laudenslager J; Koriazova L; Tahara T; Kanda Y
    PLoS One; 2016; 11(5):e0154616. PubMed ID: 27171010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A modified surface killing assay (MSKA) as a functional in vitro assay for identifying protective antibodies against pneumococcal surface protein A (PspA).
    Genschmer KR; Accavitti-Loper MA; Briles DE
    Vaccine; 2013 Dec; 32(1):39-47. PubMed ID: 24211169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal surface protein A is expressed in vivo, and antibodies to PspA are effective for therapy in a murine model of pneumococcal sepsis.
    Swiatlo E; King J; Nabors GS; Mathews B; Briles DE
    Infect Immun; 2003 Dec; 71(12):7149-53. PubMed ID: 14638806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Immunoprotective Proteins of Streptococcus pneumoniae Identified by Opsonophagocytosis Killing Screen.
    Wang Y; Wen Z; Pan X; Briles DE; He Y; Zhang JR
    Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29891544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between in vitro complement deposition and passive mouse protection of anti-pneumococcal surface protein A monoclonal antibodies.
    Khan N; Qadri RA; Sehgal D
    Clin Vaccine Immunol; 2015 Jan; 22(1):99-107. PubMed ID: 25410204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of opsonic and nonopsonic serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibodies against intranasal challenge with Streptococcus pneumoniae in mice.
    Tian H; Weber S; Thorkildson P; Kozel TR; Pirofski LA
    Infect Immun; 2009 Apr; 77(4):1502-13. PubMed ID: 19168739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Modified Surface Killing Assay Distinguishes between Protective and Nonprotective Antibodies to PspA.
    Genschmer KR; Vadesilho CFM; McDaniel LS; Park SS; Hale Y; Miyaji EN; Briles DE
    mSphere; 2019 Dec; 4(6):. PubMed ID: 31826968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a modified opsonophagocytic killing assay for anti-pneumococcal surface protein A antibody.
    Kuroda E; Koizumi Y; Piao Z; Nakayama H; Tomono K; Oishi K; Hamaguchi S; Akeda Y
    J Microbiol Methods; 2023 Sep; 212():106804. PubMed ID: 37543109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broadly Reactive Human Monoclonal Antibodies Targeting the Pneumococcal Histidine Triad Protein Protect against Fatal Pneumococcal Infection.
    Huang J; Gingerich AD; Royer F; Paschall AV; Pena-Briseno A; Avci FY; Mousa JJ
    Infect Immun; 2021 Apr; 89(5):. PubMed ID: 33649050
    [No Abstract]   [Full Text] [Related]  

  • 10. Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection.
    Chen A; Mann B; Gao G; Heath R; King J; Maissoneuve J; Alderson M; Tate A; Hollingshead SK; Tweten RK; Briles DE; Tuomanen EI; Paton JC
    Clin Vaccine Immunol; 2015 Oct; 22(10):1079-89. PubMed ID: 26245351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface.
    Ren B; Szalai AJ; Hollingshead SK; Briles DE
    Infect Immun; 2004 Jan; 72(1):114-22. PubMed ID: 14688088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
    Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
    Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a conjugate vaccine against invasive pneumococcal disease based on capsular polysaccharides coupled with PspA/family 1 protein of Streptococcus pneumoniae.
    Lin H; Peng Y; Lin Z; Zhang S; Guo Y
    Microb Pathog; 2015; 83-84():35-40. PubMed ID: 25959527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope mapping of pneumococcal surface protein A of strain Rx1 using monoclonal antibodies and molecular structure modelling.
    Kolberg J; Aase A; Rødal G; Littlejohn JE; Jedrzejas MJ
    FEMS Immunol Med Microbiol; 2003 Dec; 39(3):265-73. PubMed ID: 14642312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against systemic fatal pneumococcal infection by maternal intranasal immunization with pneumococcal surface protein A (PspA).
    Katsurahara T; Hotomi M; Yamauchi K; Billal DS; Yamanaka N
    J Infect Chemother; 2008 Dec; 14(6):393-8. PubMed ID: 19089550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17A and complement contribute to killing of pneumococci following immunization with a pneumococcal whole cell vaccine.
    Campos IB; Herd M; Moffitt KL; Lu YJ; Darrieux M; Malley R; Leite LC; Gonçalves VM
    Vaccine; 2017 Mar; 35(9):1306-1315. PubMed ID: 28161422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies.
    da Silva MA; Converso TR; Gonçalves VM; Leite LCC; Tanizaki MM; Barazzone GC
    Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28637805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with LytB protein of Streptococcus pneumoniae activates complement-mediated phagocytosis and induces protection against pneumonia and sepsis.
    Corsini B; Aguinagalde L; Ruiz S; Domenech M; Antequera ML; Fenoll A; García P; García E; Yuste J
    Vaccine; 2016 Dec; 34(50):6148-6157. PubMed ID: 27840016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A.
    Singh R; Singh S; Sharma PK; Singh UP; Briles DE; Hollingshead SK; Lillard JW
    PLoS One; 2010 Feb; 5(2):e9432. PubMed ID: 20195541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genetic background of Streptococcus pneumoniae affects protection in mice immunized with PspA.
    He X; McDaniel LS
    FEMS Microbiol Lett; 2007 Apr; 269(2):189-95. PubMed ID: 17355599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.